Neuraminidase inhibitors for influenza: Fully evaluating benefits and harms
- Andreas Handel(corresponding author),
- Mark H. Ebell
- University of Georgia,
Scholary Output:
Contribution to journal
Letter
Peer-reviewOpen access
Publication Information
Output type
Scholary Output:
Contribution to journal
Letter
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages e7-e8Journal (Volume, Issue Number)
The Lancet Respiratory Medicine (Volume 3, Issue 3)Publication milestones
- Published - 03/01/2015
Publication status
Published - 03/01/2015
ISSN
2213-2600Publication IDs
- Scopus: 84924292591
- PubMed: 25773218
Publication metrics
Metrics
SciVal
FWCI
0.43
SciVal
Author count
2
SciVal
citations
2
SciVal
Paper percentile
40
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Citation count
2
Captures
7
